82 related articles for article (PubMed ID: 22488120)
1. Absorption and bioavailability of glucosamine in the rat.
Ibrahim A; Gilzad-kohan MH; Aghazadeh-Habashi A; Jamali F
J Pharm Sci; 2012 Jul; 101(7):2574-83. PubMed ID: 22488120
[TBL] [Abstract][Full Text] [Related]
2. Single dose pharmacokinetics and bioavailability of butyryl glucosamine in the rat.
Aghazadeh-Habashi A; Ibrahim A; Carran J; Anastassiades T; Jamali F
J Pharm Pharm Sci; 2006; 9(3):359-64. PubMed ID: 17207418
[TBL] [Abstract][Full Text] [Related]
3. Single dose pharmacokinetics and bioavailability of glucosamine in the rat.
Aghazadeh-Habashi A; Sattari S; Pasutto F; Jamali F
J Pharm Pharm Sci; 2002; 5(2):181-4. PubMed ID: 12207871
[TBL] [Abstract][Full Text] [Related]
4. Bioavailability enhancement of glucosamine hydrochloride by chitosan.
Qian S; Zhang Q; Wang Y; Lee B; Betageri GV; Chow MS; Huang M; Zuo Z
Int J Pharm; 2013 Oct; 455(1-2):365-73. PubMed ID: 23830943
[TBL] [Abstract][Full Text] [Related]
5. The bioavailability and pharmacokinetics of glucosamine hydrochloride and low molecular weight chondroitin sulfate after single and multiple doses to beagle dogs.
Adebowale A; Du J; Liang Z; Leslie JL; Eddington ND
Biopharm Drug Dispos; 2002 Sep; 23(6):217-25. PubMed ID: 12214321
[TBL] [Abstract][Full Text] [Related]
6. Bioavailability of nevirapine in rats after oral and subcutaneous administration, in vivo absorption from gastrointestinal segments and effect of bile on its absorption from duodenum.
Usach I; Peris JE
Int J Pharm; 2011 Oct; 419(1-2):186-91. PubMed ID: 21843608
[TBL] [Abstract][Full Text] [Related]
7. The bioavailability and pharmacokinetics of glucosamine hydrochloride and chondroitin sulfate after oral and intravenous single dose administration in the horse.
Du J; White N; Eddington ND
Biopharm Drug Dispos; 2004 Apr; 25(3):109-16. PubMed ID: 15083499
[TBL] [Abstract][Full Text] [Related]
8. [Relative bioavailability of glucosamine after oral, intramuscular and transdermal administration of hondroxid maximum preparation in experiment].
Yasso B; Li Y; Alexander A; Mel'nikova NB; Mukhina IV
Eksp Klin Farmakol; 2014; 77(12):26-32. PubMed ID: 25739190
[TBL] [Abstract][Full Text] [Related]
9. Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review.
Setnikar I; Rovati LC
Arzneimittelforschung; 2001 Sep; 51(9):699-725. PubMed ID: 11642003
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of miglitol. Absorption, distribution, metabolism, and excretion following administration to rats, dogs, and man.
Ahr HJ; Boberg M; Brendel E; Krause HP; Steinke W
Arzneimittelforschung; 1997 Jun; 47(6):734-45. PubMed ID: 9239452
[TBL] [Abstract][Full Text] [Related]
11. Presystemic elimination of the beta-blocker pafenolol in the rat after oral and intraperitoneal administration and identification of a main metabolite in both rats and humans.
Lennernäs H; Renberg L; Hoffmann KJ; Regårdh CG
Drug Metab Dispos; 1993; 21(3):435-40. PubMed ID: 8100498
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and multiple peaking of acebutolol enantiomers in rats.
Piquette-Miller M; Jamali F
Biopharm Drug Dispos; 1997 Aug; 18(6):543-56. PubMed ID: 9267686
[TBL] [Abstract][Full Text] [Related]
13. Preclinical pharmacokinetic evaluation of resveratrol trimethyl ether in sprague-dawley rats: the impacts of aqueous solubility, dose escalation, food and repeated dosing on oral bioavailability.
Lin HS; Ho PC
J Pharm Sci; 2011 Oct; 100(10):4491-500. PubMed ID: 21520090
[TBL] [Abstract][Full Text] [Related]
14. Synovial fluid levels and serum pharmacokinetics in a large animal model following treatment with oral glucosamine at clinically relevant doses.
Laverty S; Sandy JD; Celeste C; Vachon P; Marier JF; Plaas AH
Arthritis Rheum; 2005 Jan; 52(1):181-91. PubMed ID: 15641100
[TBL] [Abstract][Full Text] [Related]
15. Effects of quercetin on the pharmacokinetics of Etoposide after oral or intravenous administration of etoposide in rats.
Li X; Choi JS
Anticancer Res; 2009 Apr; 29(4):1411-5. PubMed ID: 19414395
[TBL] [Abstract][Full Text] [Related]
16. Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL.
Kamath AV; Wang J; Lee FY; Marathe PH
Cancer Chemother Pharmacol; 2008 Mar; 61(3):365-76. PubMed ID: 17429625
[TBL] [Abstract][Full Text] [Related]
17. Tiliroside, a glycosidic flavonoid, inhibits carbohydrate digestion and glucose absorption in the gastrointestinal tract.
Goto T; Horita M; Nagai H; Nagatomo A; Nishida N; Matsuura Y; Nagaoka S
Mol Nutr Food Res; 2012 Mar; 56(3):435-45. PubMed ID: 22173993
[TBL] [Abstract][Full Text] [Related]
18. Quercetin increases the bioavailability of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in rats.
Schutte ME; Alink GM; Freidig AP; Spenkelink B; Vaessen JC; van de Sandt JJ; Groten JP; Rietjens IM
Food Chem Toxicol; 2008 Nov; 46(11):3422-8. PubMed ID: 18783729
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of nebivolol in the rat: low oral absorption, loss in the gut and systemic stereoselectivity.
Sanaee F; Valente Neves D; Lanchote VL; Jamali F
Biopharm Drug Dispos; 2013 Sep; 34(6):312-20. PubMed ID: 23625744
[TBL] [Abstract][Full Text] [Related]
20. Enhanced bioavailability of tamoxifen after oral administration of tamoxifen with quercetin in rats.
Shin SC; Choi JS; Li X
Int J Pharm; 2006 Apr; 313(1-2):144-9. PubMed ID: 16516418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
